MADRIGAL PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Madrigal Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q2 2024.
  • Madrigal Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 43.3 %, a 71.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 43.3 -107 -71.2% Jun 30, 2024
Q1 2024 63.8 -78.5 -55.2% Mar 31, 2024
Q4 2023 122 +2.59 +2.17% Dec 31, 2023
Q3 2023 161 +61.3 +61.4% Sep 30, 2023
Q2 2023 150 +96.4 +178% Jun 30, 2023
Q1 2023 142 +109 +329% Mar 31, 2023
Q4 2022 120 +93.2 +354% Dec 31, 2022
Q3 2022 99.8 +77.6 +349% Sep 30, 2022
Q2 2022 54 +34.9 +182% Jun 30, 2022
Q1 2022 33.2 +16.3 +96.3% Mar 31, 2022
Q4 2021 26.4 +13 +96.8% Dec 31, 2021
Q3 2021 22.2 +12 +117% Sep 30, 2021
Q2 2021 19.2 +12.1 +169% Jun 30, 2021
Q1 2021 16.9 +12.2 +258% Mar 31, 2021
Q4 2020 13.4 +9.72 +265% Dec 31, 2020
Q3 2020 10.2 +7.62 +291% Sep 30, 2020
Q2 2020 7.12 +5.05 +244% Jun 30, 2020
Q1 2020 4.72 +3.07 +186% Mar 31, 2020
Q4 2019 3.66 +2.01 +122% Dec 31, 2019
Q3 2019 2.62 +0.48 +22.4% Sep 30, 2019
Q2 2019 2.07 -1.3 -38.6% Jun 30, 2019
Q1 2019 1.65 -4.94 -75% Mar 31, 2019
Q4 2018 1.65 -7.64 -82.2% Dec 31, 2018
Q3 2018 2.14 -11.6 -84.4% Sep 30, 2018
Q2 2018 3.37 -9.01 -72.8% Jun 30, 2018
Q1 2018 6.59 -5.4 -45% Mar 31, 2018
Q4 2017 9.29 -3.66 -28.2% Dec 31, 2017
Q3 2017 13.7 -73.7 -84.3% Sep 30, 2017
Q2 2017 12.4 -82 -86.9% Jun 30, 2017
Q1 2017 12 -85.1 -87.6% Mar 31, 2017
Q4 2016 13 -102 -88.7% Dec 31, 2016
Q3 2016 87.4 -11.5 -11.6% Sep 30, 2016
Q2 2016 94.4 +4.3 +4.77% Jun 30, 2016
Q1 2016 97.1 +3.95 +4.24% Mar 31, 2016
Q4 2015 115 +10.3 +9.78% Dec 31, 2015
Q3 2015 98.9 +28.8 +41% Sep 30, 2015
Q2 2015 90.1 -8.84 -8.93% Jun 30, 2015
Q1 2015 93.1 -31.1 -25% Mar 31, 2015
Q4 2014 105 -0.27 -0.26% Dec 31, 2014
Q3 2014 70.2 -9.95 -12.4% Sep 30, 2014
Q2 2014 99 +34.2 +52.9% Jun 30, 2014
Q1 2014 124 +60.6 +95.4% Mar 31, 2014
Q4 2013 105 +39.4 +60% Dec 31, 2013
Q3 2013 80.1 -24.4 -23.3% Sep 30, 2013
Q2 2013 64.7 -52.4 -44.8% Jun 30, 2013
Q1 2013 63.6 Mar 31, 2013
Q4 2012 65.7 Dec 31, 2012
Q3 2012 104 Sep 30, 2012
Q2 2012 117 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.